Skip to content

Intraparenchymal stapler resection of the pedicle vs. hilar preparation for right hepatectomy – a randomized controlled trial

Intraparenchymal stapler resection of the pedicle vs. hilar preparation for right hepatectomy – a randomized controlled trial - STARSHIP

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032672
Enrollment
165
Registered
2023-09-21
Start date
2023-10-23
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of surgical technique in the context of right hemihepatectomy

Interventions

Group 1: Parenchymal dissection and intraparenchymal dissection of the hepatic pedicle via stapler Group 2: Extrahepatic approach with hilar preparation

Sponsors

Charité Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Indication: Patients with (histologically confirmed or clinically suspected) primarily resectable benign or malign primary or secondary liver tumors 2. Surgical extend: minimal-invasive right hepatectomy (or extended right) , indication for right hepatectomy must be confirmed by two experienced liver surgeons 3. Multidisciplinary tumor board recommendation in patients with malignancies 4. Written informed consent of the participating person 5. ECOG = 2

Exclusion criteria

Exclusion criteria: 1. Hepatobiliary reconstruction necessary 2. Open surgery, hybrid surgery, hand-assisted surgery 3. Simultaneous resection of liver (-metastases) and primary tumor/other organs 4. Pregnant or breast-feeding women 5. Indications that the patient is unlikely to comply with the protocol (e.g. unwillingness to cooperate) 6. Thrombosis close to the bifurcation of the portal vein

Design outcomes

Primary

MeasureTime frame
Postoperative complications using the Comprehensive Complication Index (CCI)

Secondary

MeasureTime frame
surgical radicality using the resection margin (R0) length of hospital stay postoperative serum aminotransferases 30-day mortality intraoperative blood loss operative time Disease free survival (DFS) overall survival (OS)

Countries

Germany

Contacts

Public ContactRamin Raul Ossami Saidy

Charité Universitäsmedizin Berlin

ramin-raul.ossami-saidy@charite.de+4903652557

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026